The success of an experiment involving lentiviral delivery technology is often dependent upon the efficiency with which the genetic payload is delivered into the target cells. Adding SureENTRY Transduction Reagent to the transduction protocol dramatically improves the efficiency of lentiviral/retroviral delivery. SureENTRY Transduction Reagent is a valuable addition to any experiment using Cignal Lenti Reporter Assays and its ready-to-use, optimized formulation means that there is no need to screen numerous transduction reagent formulations.